[Methylguanidine and excretory pancreatic function: a model for uraemic pancreatic disease? (author's transl)].
D000818:Animals; D002415:Cats; D004195:Disease Models, Animal; D006146:Guanidines / Q000008:administration & dosage / Q000009:adverse effects / Q000633:toxicity*; D006801:Humans; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D010179:Pancreas / Q000378:metabolism; D010182:Pancreatic Diseases / Q000139:chemically induced*; D010187:Pancreatic Hormones / Q000494:pharmacology; D014176:Protein Biosynthesis; D012039:Regional Blood Flow / Q000187:drug effects; D013268:Stimulation, Chemical; D014511:Uremia / Q000139:chemically induced*
D006146:Guanidines; D010187:Pancreatic Hormones
Methylguanidin und exokrine Pankreasfunktion - ein Modell der urämischen Pankreopathie?